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reported Case summary 
Iowa May 2016 The Iowa Statewide Poison Control received notification of a woman aged 57 years 
who had been taking tianeptine powder (unknown dose) up to 7 times/day for the 
last 6–12 months and stopped taking it one day before her emergency department 
(ED) visit. In the ED, she complained of dyspnea, watery diarrhea, skin crawling 
sensation, anxiety, and cramping in her hands and fingers. She was not taking other 
supplements. Urine drug screen and tianeptine levels were not performed. The 
patient was hypokalemic (potassium of 2 mEq/L [normal = 3.7–5.2]) throughout her 
hospitalization and required daily potassium supplementation. She was also treated 
with intravenous fluids, lorazepam, and bicarbonate therapy. On the first hospital 
day, she deteriorated and was intubated. During her hospital stay, she was treated 
with labetalol, hydralazine, propofol, lorazepam, and midazolam. The patient was 
extubated on day 5 and discharged home on day 7 in her usual state of health, 
except for persistent hypokalemia (potassium of 3 mEq/L). 
Michigan August 2016 The Children’s Hospital of Michigan Regional Poison Center was notified about a man 
aged 23 years who was evaluated in the ED for a seizure after taking an unknown 
quantity of tianeptine that was purchased online. The patient developed agitation, 
hyperthermia, tachycardia, hypertension, tremors, clonus, rigidity, hyperreflexia, 
hallucinations, and rhabdomyolysis over the course of his seven-day hospital stay. 
Despite lorazepam and dexmedetomidine infusion, the patient remained severely 
agitated requiring intubation and sedation with propofol, midazolam, and valproic 
acid. He was also treated with metoprolol and clonidine for his hypertension and 
tachycardia. The patient’s mental status improved on hospital day 2 and he was 
extubated on day 3. His creatine kinase peaked at 28,000 U/L. The patient was 
discharged on day 7 after return to baseline mental status, improvement of his 
clonus, and decreasing creatine kinase.  
 
